Company: WHWK
Filing Date: 2025-02-19
Form Type: DEFA14A
Source: 0001193125-25-029692
Chunk: 4

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-02-19
Form: DEFA14A
Chunk 4
---
.aadibio.com

No Offer or Solicitation

This communication shall not constitute an offer to sell or a solicitation of an offer to buy these securities nor a solicitation of any vote or approval with
respect to the proposed transactions or otherwise, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of any such state or other jurisdiction.

The offer and sale of securities of Aadi described above are being made in a transaction not
involving a public offering and the securities have not been registered under the Securities Act of 1933, as amended, and may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable
exemption from the registration requirements. Concurrently with the closing of the subscription agreement for the financing, the Company and the investors will enter into a registration rights agreement pursuant to which the Company will file,
following the closing of the financing, a registration statement with the SEC registering the resale of the shares of Common Stock and the shares of Common Stock underlying the Pre-Funded Warrants sold in the
PIPE financing.

Aadi Bioscience, Inc.
• Two Headquarters Plaza, Morristown, NJ, 07960, USA • www.aadibio.com